Teresa
Binstock
Researcher in Developmental & Behavioral Neuroanatomy
February 15, 2010
Circa 2010, the MMR
autism controversy has not abated despite The Lancet's retraction of a
peer-reviewed case-studies paper the journal's editor Richard Horton
has described as scientifically sound (1-2). Indeed, the primary reason
for the retraction appears to have been the researchers' having
considered the possibility that the MMR vaccination may have initiated
some children's regression into autism with gastrointestinal pathology
(3).
There are two primary issues: Are measles mumps rubella (MMR)
vaccinations etiologically significant in some cases of regressive
autism? Are MMR vaccinations etiologically significant in the
gastrointestinal pathology of some autistic children?
Mainstream media would have us believe the answer to each question is
no: The MMR is neither a causal factor nor a co-factor in some cases of
autism and has no relevance to intestinal pathologies in subgroups of
children with autism or one of the other autism-spectrum disorders.
However, findings in other peer-reviewed studies are consistent with
the idea that MMR vaccinations induce adverse sequelae in some
children.
Part 1: Richard
Horton, The Lancet editor, affirms sound science in Wakefield et al
1998
In 2006, The Observer, a major London news magazine, printed an article
by Sally Beck, wherein The Lancet editor Richard Horton said the
scientific findings in Wakefield et al 1998 were valid.
'Horton was quick to confirm that the science
in the paper, which looked at whether 12 autistic children also
suffered bowel disease, was good.
'He reiterated his statement in his evidence
to the GMC, "There was no question in my mind that subject to external
peer review and editor debate, we should publish this work," he said.
"The description of what seemed to be a new syndrome and its relations
to possible environmental triggers was original and would certainly
have interested our readers." ' (2)
Furthermore, the 1998, Wakefield et al finding of gastrointestinal
pathology in a subgroup of autistic children has been confirmed
numerously (4-11; see also 12-13); and in 2010, the American Academy of
Pediatrics journal "Pediatrics" published two major reviews focusing
upon evaluation and treatment of gastrointestinal pathologies in
autistic children (14-15; see also 16-17).
Part 2: Richard Horton, The Lancet editor,
reverses himself
In 2010, an article in the New York Times (18) made clear that Richard
Horton is reversing his 2006 statements. He denounces the Wakefield et
al 1998 study and -- perhaps most importantly -- admits that the 1998
article's vaccine/autism speculation became The Lancet's error which
led to retraction. Consider statements from NYTimes blogger Tara Parker
Pope:
'The study was retracted after concerns about
ethical breaches by one of the study authors. In addition, 10 of the 13
co-authors have disavowed the study’s conclusions. ”We fully retract
this paper from the published record,” The Lancet editors said in a
statement.
'But the damage has been done. The paper has
fueled fears about the risks of childhood vaccinations and autism,
particularly the M.M.R. vaccine, despite numerous studies showing no
link.
'This week, National Public Radio’s “On the
Media” explored the role the media played in inflaming fears about
vaccines and autism, asking how “bad science” made its way into The
Lancet and the “collective psyche.”...'
(18)
Irony abounds. A study whose findings have been numerously replicated
has been retracted. Thus the 1998 article's primary conclusion - the
description of a finding of gastrointestinal pathology in a subgroup of
autistic children - is not going away. Perhaps the recantation by 10 of
the 13 co-authors and the retraction by The Lancet was less about the
intestinal pathology findings and more about the researchers having
dared consider the possibility that, for some children, their
regression into autism and their gastrointestinal pathology may have
been initiated by the MMR vaccination.
Not suprisingly, Timothy Buie, M.D., and colleagues have been able to
understand and express the core concern:
"In 1998, Wakefield et al... reported an
association between ileocolitis and developmental regression in 12
children and coined the term “autistic enterocolitis.” From the same
uncontrolled study they reported NLH [nodular lymphoid hyperplasia] of
the ileum and colon as an abnormal finding in most children with
ASDs... Wakefield et al also proposed [and stated as not proven] a
causal relation between measles, mumps, and rubella (MMR) vaccination
and autism, a suggestion that was later retracted by many of the
original authors." (14)
Now, why would the editor of a prominent journal like The Lancet
reverse himself so completely? The answer may have been presented in
the aforementioned NYTimes article, where Horton mentions new vaccines
about to enter the market.
"I certainly hope that our retraction today
will help to reassure parents that there really isn’t anything to be
concerned about with the vaccine. I think there’s a history over many
hundreds of years of anti-vaccine movements. We are going to see many,
many more vaccines available to the general public, and we all have to
be very vigilant about making sure that we build trust and confidence
in these vaccines which are going to transform the landscape of health
over the next generation." (18)
If data indicate an association between vaccinations and various
autism-spectrum disorders, then new vaccines might be less well
received. Should that happen, gross revenues and net profits for
pharmaceutical companies that manufacture vaccines would be negatively
impacted. Thus let us ask, is there evidence that MMR vaccinations may
injure some children? According to peer-reviewed studies, the answer is
Yes.
Part 3: The MMR and adverse
events
NVICP: National Vaccine Injury Compensation Program (19)
VAERS: Vaccine Adverse Event Reporting System (20)
NVICP and VAERS exist because adverse effects associated with
vaccinations have long been known. Although NVICP and VAERS recommend
that even soft signals (reports of adverse reactions) merit concern,
the emphasis for seeking soft signals is via professionals with
credentials (20). In this schema, parental reports tend to remain
virtually unheard. A major part of the heresy of Wakefield and his
colleagues in 1998 is (a) they listened to parents who reported
MMR-related regression into autism and MMR-related onset of bowel
pathology, and (b) the researchers dared commit these parental
observations into print in a prominent medical journal (1).
Circa 1997 and 1998 - give or take a few years - considering adverse
effects from vaccinations was common and was enacted by researchers, by
peer-reviewers, and by editors. For example, the NVICP's Robert E.
Weibel, M.D. and colleagues had written a vaccination-effects study
published in Pediatrics (23) one month after Wakefield et al 1998 was
published in The Lancet (1; February 1998).
Weibel et al titled their study, "Acute Encephalopathy Followed by
Permanent Brain Injury or Death Associated With Further Attenuated
Measles Vaccines..." and concluded "...that a causal relationship
between measles vaccine and encephalopathy may exist as a rare
complication of measles immunization", whether from the measles
vaccine, the measles-rubella vaccine, or the MMR (23).
Given that studies like Weibel et al 1998 were addressing legitimate
concerns and were passing peer-review in prominent journals, Wakefield
et al's speculation about possible links between the MMR and a
regressive autism subgroup with gastrointestinal pathology was not as
egregiously out-of-bounds as Richard Horton and major media would have
us believe in 2010.
Part 4: a brief look at Weibel et al
1998
A. Published in March of 1998, the Weibel et al paper was in the
pre-publication, peer-review process virtually the same time as was
Wakefield et al 1998.
B. After major exclusions intended to eliminate co-factor influences,
48 severe adverse effects from MMR were identified amid NVCIP data.
C. The 48 cases of adverse effects were summarized as follows:
"Eight children died, and the remainder had
mental regression and retardation, chronic seizures, motor and sensory
deficits, and movement disorders." (23)
Notice that Weibel et al's summary of findings is remarkably similar to
traits described in PDD/NOS!
D. Subsequent reviews of MMR safety often interpret Weibel et al 1998
as showing how rare MMR adversities are.
E. Some MMR analyses cite Weibel et al 1998 as showing that adverse
effects of MMR vaccinations are known and can be severe. Indeed, Weibel
et al's MMR findings are consistent with more recent analyses,
"Statistically significant increases in the incidence of serious
neurologic disorders following pediatric MMR vaccine in comparison to
DTwcP vaccine were found." (24) and "...there is biological
plausibility and epidemiological evidence showing a direct relationship
between... measles-containing vaccines and serious neurological
disorders." (25)
F. The schedule of vaccinations for children in the U.S. and U.K. has
increased dramatically since most years included the the Weibel et al
analysis, and this increase has occurred in the absence of studies
comparing adverse events in vaccinated and unvaccinated children.
G. Exclusions in Weibel et al 1998 are significant and suggest that the
study's 48 severe MMR-related injuries may be the tip of a huge
iceberg.
Part 5: Exclusions in Weibel et al
1998
The exclusion criteria used by Weibel and colleagues were important to
their study's focus and to the researchers' ability to justify their
conclusions. Nonetheless, the study's exclusions and several other
factors suggest that Weibel et al's 48 severely injured children may
represent a large under-estimation, as suggested by the data of Geier
et al (24-25) and as reported by numerous parents including those in
the study by Wakefield et al 1998 (1).
A. "Postinfectious encephalopathy complicates approximately 1 in 1000
cases of natural measles and results in a mortality rate of 10% to 20%
and permanent central nervous system impairment in the majority of
survivors... Case reports and reviews suggest that similar neurologic
complications can, less frequently, follow the administration of live
attenuated measles vaccine..." (23)
B. From 403 claims submitted to 48 cases included in the study:
"A total of 403 claims of encephalopathy and/or seizure
disorder after measles, MR, MMR, mumps, or rubella vaccination were
identified during this 23-year period. Of these claims, 48 (25 males
and 23 females) met the inclusion criteria and acquired an acute
encephalopathy of undetermined cause 2 to 15 days after receiving
measles vaccine, MR, or MMR." (23)
C. Underreporting:
Weibel et al 1998: "The 48 cases of encephalopathy probably
represent underreporting to this passive system, which does not require
individuals to file for compensation and requires medical
documentation." (23) "
FDA summary of reporting: "FDA receives by direct report less
than 1% of suspected serious ADRs... This means that cases
spontaneously reported to any surveillance program, which comprise the
numerator, generally represent only a small portion of the number that
have actually occurred." (20)
D. Vaccine Injury Table specifies: In the absence of an alternate cause
[co-factors may cloud this issue, see below]
"For an individual who received a measles, mumps, or rubella
vaccine, the act grants, in the Vaccine Injury Table, the presumption
of vaccine causation
if the first manifestation of encephalopathy occurs, in the absence of
an alternate cause, 15 days or less after receiving any of these
vaccines. The injury or its
residual effects, except when death occurs, must persist for >6
months." (23)
E. Exclusion by decree: changing eligibility time period from onset 15
days or less to onset between days 5 to 15, thus excluding MMR-induced
deteriorations that began on days 1 thru 4 after the MMR vaccination.
In Weibel et al (Figure 1, p 385) 6 of the 48 adverse events began
prior to day 5.
"Effective March 10, 1995, the [NVICP] program changed the time
period of a Vaccine Table Injury for these vaccines and the onset of
encephalopathy from <15 days to 5 to 15 days..." (23)
F. Abrupt onset included in Weibel et al, thus gradual onset excluded
(23): Many parents have reported that their now autistic child's
MMR-induced regression began soon after the MMR vaccination but was
gradual and continued to develop (adversely) for months after the
vaccination.
G. Exclusion of postictal: "Seizures with mental dysfunction attributed
to the postictal state or medication were not considered to be
encephalopathy." (23) Since chronic seizures were the most common
adverse effect of measles, MR, and MMR vaccinations (23), to exclude
postictal mental dysfunction seems to have eliminated from
consideration neurologic deteriorations induced by seizures.
H. Infectious, toxic, metabolic exclusions: "Cases of encephalopathy
were excluded if an infectious, toxic, traumatic, or metabolic cause or
a recent exposure to natural measles, mumps, or rubella was identified
or full recovery occurred within 6 months." (23)
These three exclusions in Weibel et al 1998 have enhanced
significance in 2010. Etiologically significant co-factors abound.
Autism has long been associated with herpes simpex virus and with human
herpesvirus 6 (eg, 26-27). Various airborne pollutants are associated
with autism (28-30). Various gene alleles related to detoxification and
metabolic processes are associated with autism (eg, 31-33). And classic
mitochondrial disorders that are clinically silent prior to
vaccinations (eg, Hannah Poling) or clinically more common
mitochondrial dysfunction (34) also stand as risk factors which may be
co-active along with MMR vaccinations - especially if the child's MMR
vaccination occurs during the same incident in which a
thimerosal-containing vaccine is injected (eg, 35-36). Enforcement of a
one-size-fits-all vaccination schedule means that many children with
known risk factors are being vaccinated, including with the MMR.
Conclusions: Citations and analysis presented in this brief essay make
clear that The Lancet editor has waffled on behalf of future sales of
current and new vaccines, that Wakefield et al's 1998 speculation about
MMR vaccinations being linked with an autism subgroup were not far
afield of other peer-reviewed studies, and - as various researchers
have stated - increasing the safety of vaccinations merits ongoing
attention. Adverse events happen and need continually be minimized.
Comments in a petition on behalf of physicians Wakefield, Murch, and
Walker-Smith are informative (37).
References:
1. Ileal-lymphoid-nodular hyperplasia, non-specific
colitis, and pervasive developmental disorder in
children
Wakefield AJ et al.
Lancet. 1998 Feb 28;351(9103):637-41.
here
2. Richard Horton Waffles on
Lancet's Wakefield Retraction
Sally Beck; Feb 12, 2010
http://www.huffingtonpost.com/sally-beck/richard-horton-waffles-on_b_460550.html
3. Retracting a
Medical Journal’s Autism Study
By TARA PARKER-POPE
http://well.blogs.nytimes.com/2010/02/08/did-the-media-inflame-the-vaccine-autism-link/
4. Enterocolitis in
children with developmental disorders
Wakefield AJ et al.
Am J Gastroenterol. 2000 Sep;95(9):2285-95.
5. Colonic CD8 and
gamma delta T-cell infiltration with epithelial damage in children with
autism
Furlano RI et al.
J Pediatr. 2001 Mar;138(3):366-72.
6. The significance
of ileo-colonic lymphoid nodular hyperplasia in children with autistic
spectrum disorder
Wakefield AJ et al.
Eur J Gastroenterol Hepatol. 2005 Aug;17(8):827-36.
7. Immune activation
of peripheral blood and mucosal CD3 lymphocyte cytokine profiles in
children with autism and gastrointestinal
symptoms.
Ashwood P, Wakefield AJ.
J Neuroimmunol. 2006 Apr;173(1-2):126-34.
8. Are there more
bowel symptoms in children with autism compared to normal children and
children with other developmental and neurological disorders?: A case
control study
Smith RA et al.
Autism. 2009 Jul;13(4):343-55.
"There was a significant difference in the reporting of certain bowel
symptoms (constipation, diarrhoea, flatulence) and food faddiness
between the autism group and the mainstream school control group... It
would appear, however, that this is not specifically associated with
autism as bowel symptoms were reported in similar frequency to a
comparison group of children with other developmental and neurological
disorders."
9. Autistic
enterocolitis: Fact or fiction?
{excellent, brief overview}
P Galiatsatos, A Gologan, E Lamoureux
Can J Gastroenterol. 2009 Feb;23(2):95-8.
http://www.pulsus.com/journals/abstract.jsp?sCurrPg=journal&jnlKy=2&atlKy=8619&isuKy=837&isArt=t
10. Clinical
Presentation and Histologic Findings at Ileocolonoscopy in Children
with Autistic Spectrum Disorder and Chronic Gastrointestinal
Symptoms
Arthur Krigsman, Marvin Boris, Allan Goldblatt and Carol Stott
Autism Insights 2010:2 1-11; 27 Jan 2010
http://www.la-press.com/clinical-presentation-and-histologic-findings-at-ileocolonoscopy-in-ch-a1816
11. Gastrointestinal
Pathology in Autism Spectrum Disorders: The Venezuelan Experience
Lenny G. Gonzalez, MD
http://www.autismone.org/content/gastrointestinal-pathology-autism-spectrum-disorders-venezuelan-experience-lenny-g-gonzalez-
12. On Second Looking
into the Case of Dr. Andrew J. Wakefield
William Long, MDiv, PhD, JD
http://www.autismone.org/content/second-looking-case-dr-andrew-j-wakefield-william-long-mdiv-phd-jd
13. Gastrointestinal
pathologies in autism: Did Mayo's Ibrahim and colleagues
err?
Teresa Binstock, Jan 31, 2010.
http://www.generationrescue.org/binstock/100131-autism-gastrointestinal-misleading-study.htm
14. Evaluation,
Diagnosis, and Treatment of Gastrointestinal Disorders in Individuals
With ASDs: A Consensus Report
Buie T et al.
Pediatrics 2010;125:S1–S18.
http://pediatrics.aappublications.org/cgi/content/full/125/Supplement_1/S1
15. Recommendations
for Evaluation and Treatment of Common Gastrointestinal Problems in
Children With ASDs
Buie T et al.
Pediatrics 2010;125:S19–S29
http://pediatrics.aappublications.org/cgi/content/full/125/Supplement_1/S19
16. On Second Looking
into the Case of Dr. Andrew J. Wakefield
William Long, MDiv, PhD, JD
http://www.autismone.org/content/second-looking-case-dr-andrew-j-wakefield-william-long-mdiv-phd-jd
17. Gastrointestinal
pathologies in autism: Did Mayo's Ibrahim and colleagues
err?
Teresa Binstock, Jan 31, 2010.
http://www.generationrescue.org/binstock/100131-autism-gastrointestinal-misleading-study.htm
18. Retracting a
Medical Journal’s Autism Study
By TARA PARKER-POPE
http://well.blogs.nytimes.com/2010/02/08/did-the-media-inflame-the-vaccine-autism-link/
19. NVICP
http://www.hrsa.gov/vaccinecompensation/default.htm
20. The Clinical
Impact of Adverse Event Reporting
FDA, 1996.
http://www.fda.gov/downloads/Safety/MedWatch/UCM168505.pdf
21. Vaccine Adverse
Event Reporting System (VAERS)
HHS
http://vaers.hhs.gov/index
22. Post-marketing
surveillance for adverse events after vaccination: the national Vaccine
Adverse Event Reporting System (VAERS)
FDA, 1998.
http://www.fda.gov/downloads/Safety/MedWatch/UCM168497.pdf
23. Acute
Encephalopathy Followed by Permanent Brain Injury or Death Associated
With Further Attenuated Measles Vaccines: A Review of Claims Submitted
to the National Vaccine Injury Compensation
Program
Received Jul 30, 1997; accepted Sep 23, 1997.
Robert E. Weibel*, Vito Caserta*, David E. Benor Dagger, and Geoffrey
Evans*
>From the * Division of Vaccine Injury Compensation, National
Vaccine Injury Compensation Program, Health Resources and Services
Administration, Public Health Service, Rockville, Maryland; and the
Dagger Office of the General Counsel, United States Department of
Health and Human Services, Rockville, Maryland.
PEDIATRICS Vol. 101 No. 3 March 1998, pp. 383-387
http://pediatrics.aappublications.org/cgi/content/abstract/101/3/383
{some highlights added in abstract}
Objective. To determine if there is evidence for a causal relationship
between acute encephalopathy followed by permanent brain injury or
death associated with the administration of further attenuated measles
vaccines (Attenuvax or Lirugen, Hoechst
Marion Roussel, Kansas City, MO), mumps vaccine (Mumpsvax, Merck
and Co, Inc, West Point, PA), or rubella vaccines (Meruvax or
Meruvax II, Merck and Co, Inc, West Point, PA), combined measles and rubella
vaccine (M-R-Vax or M-R-Vax II, Merck and Co, Inc, West
Point, PA), or combined measles,
mumps, and rubella vaccine (M-M-R or M-M-R
II, Merck and Co, Inc, West Point, PA), the lead author reviewed claims
submitted to the National Vaccine Injury Compensation Program.
Methods. The medical records of children who met the inclusion
criteria of receiving the first dose of these vaccines between 1970 and
1993 and who developed such an encephalopathy with no determined cause
within 15 days were identified and analyzed.
Results. A total of 48 children, ages 10 to 49 months, met the
inclusion criteria after receiving measles vaccine, alone or in
combination. Eight children died, and the remainder had mental
regression and retardation, chronic seizures, motor and sensory
deficits, and movement disorders. The onset of neurologic signs or
symptoms occurred with a nonrandom, statistically significant
distribution of cases on days 8 and 9. No cases were identified after
the administration of monovalent mumps or rubella vaccine.
Conclusions. This
clustering suggests that a causal relationship between measles vaccine
and encephalopathy may exist as a rare complication of measles
immunization.
24. Pediatric MMR
Vaccination Safety
Mark R. Geier, MD, PhD; David A Geier
International Pediatrics 2003;18(2):203-208.
Measles, mumps and rubella are viral infections that have the potential
to result in globally destructive disorders. Measles, mumps and rubella
(MMR) vaccine has helped to dramatically reduce the number of cases of
measles, mumps and rubella infection, as well as to reduce the amount
of pain and suffering associated with each of these natural infections.
The purpose of this study was to analyze the incidence of serious
neurologic disorders in a comparative examination between MMR vaccine
and a vaccine control group. The Vaccine Adverse Events Reporting
System (VAERS) database was analyzed for the incidence rate of
permanent brain damage, cerebellar ataxia, autism and mental
retardation reported following MMR vaccine and diphtheria, tetanus and
whole-cell pertussis (DTwcP) containing-vaccines from 1994 through 2000
in the US. Statistically
significant increases in the incidence of serious neurologic disorders
following pediatric MMR vaccine in comparison to DTwcP vaccine were
found. The potentially globally
destructive effects of natural measles, mumps and rubella infections
means that continued vaccination is necessary, but improvements in MMR
vaccines are needed to improve its safety.
25. A comparative
evaluation of the effects of MMR immunization and mercury doses from
thimerosal-containing childhood vaccines on the population prevalence
of autism.
Geier DA, Geier MR.
Med Sci Monit. 2004 Mar;10(3):PI33-9. Epub 2004 Mar 1.
BACKGROUND: The purpose of the study was to evaluate the effects of MMR
immunization and mercury from thimerosal-containing childhood vaccines
on the prevalence of autism. MATERIAL/METHODS: Evaluations of the
Biological Surveillance Summaries of the Centers for Disease Control
and Prevention (CDC), the U.S. Department of Education datasets, and
the CDC's yearly live birth estimates were undertaken RESULTS: It was
determined that there was a close correlation between mercury doses
from thimerosal--containing childhood vaccines and the prevalence of
autism from the late 1980s through the mid-1990s. In contrast, there
was a potential correlation between the number of primary pediatric
measles-containing vaccines administered and the prevalence of autism
during the 1980s. In addition, it was found that there were
statistically significant odds ratios for the development of autism
following increasing doses of mercury from thimerosal-containing
vaccines (birth cohorts: 1985 and 1990-1995) in comparison to a
baseline measurement (birth cohort: 1984). The contribution of
thimerosal from childhood vaccines (>50% effect) was greater than
MMR vaccine on the prevalence of autism observed in this study.
CONCLUSIONS: The results of this study agree with a number of
previously published studies. These studies have shown that
there is biological
plausibility and epidemiological evidence showing a direct relationship
between increasing doses of mercury from
thimerosal-containing vaccines and neurodevelopmental disorders, and
measles-containing vaccines
and serious neurological disorders. It is
recommended that thimerosal be removed from all vaccines, and
additional research be undertaken to produce a MMR vaccine with an
improved safety profile.
26. Acquired
reversible autistic syndrome in acute encephalopathic illness in
children
DeLong GR, Bean SC, Brown FR 3rd.
Arch Neurol. 1981 Mar;38(3):191-4.
27. Serological
association of measles virus and human herpesvirus-6 with brain
autoantibodies in autism
Singh VK, Lin SX, Yang VC.
Clin Immunol Immunopathol. 1998 Oct;89(1):105-8.
28. Autism spectrum
disorders in relation to distribution of hazardous air pollutants in
the san francisco bay area
Windham GC, Zhang L, Gunier R, Croen LA, Grether JK.
Environ Health Perspect. 2006 Sep;114(9):1438-44.
29. Maternal
residence near agricultural pesticide applications and autism spectrum
disorders among children in the California Central
Valley
Roberts EM, English PB, Grether JK, Windham GC, Somberg L, Wolff C.
Environ Health Perspect. 2007 Oct;115(10):1482-9.
30. Proximity to
point sources of environmental mercury release as a predictor of autism
prevalence.
Palmer RF, Blanchard S, Wood R.
Health Place. 2009 Mar;15(1):18-24.
31. Metabolic
endophenotype and related genotypes are associated with oxidative
stress in children with autism.
James SJ ete al.
Am J Med Genet B Neuropsychiatr Genet. 2006 Dec 5;141B(8):947-56.
32. One Carbon
Metabolism Disturbances and the C667T MTHFR Gene Polymorphism in
Children with Autism Spectrum Disorders.
Paşca SP et al.
J Cell Mol Med. 2008 Aug 9. [Epub ahead of print]
33. Paraoxonase gene
variants are associated with autism in North America, but not in Italy:
possible regional specificity in gene-environment
interactions
D'Amelio M et al.
Mol Psychiatry. 2005 Nov;10(11):1006-16.
34. Evidence of
Mitochondrial Dysfunction in Autism and Implications for
Treatment
Daniel A. Rossignol, J. Jeffrey Bradstreet
American Journal of Biochemistry and Biotechnology 4 (2): 208-217,
2008
{free online}
http://www.scipub.org/fulltext/ajbb/ajbb42208-217.pdf
35. Hepatitis B
triple series vaccine and developmental disability in US children aged
1-9 years
Gallagher C, Goodman M. Toxicol Environ Chem 2008 90(5):997-1008.
{free online}
http://fourteenstudies.org/pdf/hep_b.pdf
"The odds of receiving EIS were approximately nine times as great for
vaccinated boys... as for unvaccinated boys..., after adjustment for
confounders.
36. Hepatitis B
vaccination of male neonates and autism
[conference abstract as published]
CM Gallagher, MS Goodman, Graduate Program in Public
Health, Stony Brook University Medical Center, Stony Brook, NY
Annals of Epidemiology, p659
Vol. 19, No. 9 Abstracts (ACE) September 2009: 651–680
[triple the rate of autism among boys vaccinated with thimerosal versus
boys not so vaccinated]
37. Petition on behalf of Wakefield, Murch, and Walker-Smith
Contact Teresa Binstock by email
Return to index of essays by Teresa
Binstock
|